Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis

Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis#Remegen #Announces #Exciting #Results #Telitacicept #Phase #Clinical #Trial #Patients #Generalized #Myasthenia #Gravis